Are Renal Cysts Cancerous? Explaining the Cancer Risk

The vast majority of renal cysts are simple, fluid-filled sacs that carry no cancer risk at all. These simple cysts are among the most common findings on abdominal imaging, turning up in roughly one in ten adults and becoming increasingly frequent with age. A small fraction of kidney cysts, however, have internal features that raise suspicion, and the cancer risk for those ranges from negligible to very high depending on what the cyst looks like on a scan. Understanding where a particular cyst falls on that spectrum is what separates a shrug-it-off finding from one that needs surgery.

How Common Renal Cysts Are

Simple renal cysts are startlingly common once you start looking. One large screening study found an overall prevalence of about 11%, with rates climbing steeply by decade: roughly 2% in people in their twenties, rising to about 35% in those past their sixties.¹ An ultrasound survey reported a similar pattern, with no cysts detected in people under 30, about 12% in those aged 50 to 70, and over 22% in people past 70.² The sheer volume of these cysts matters because it means millions of people receive an imaging report mentioning a kidney cyst every year. Almost all of them are harmless.

Most simple cysts cause no symptoms. When they grow large enough to press on nearby structures, they can cause flank pain, blood in the urine, or even a rise in blood pressure.³ One study found that having multiple or large simple cysts raised systolic blood pressure by a couple of points on average, enough to nudge some people into a higher blood-pressure category.⁴ Complications like hemorrhage into the cyst, rupture, or infection are uncommon and mostly seen in people who have polycystic kidney disease rather than a solitary simple cyst.⁵

The Bosniak Classification and What It Means for You

Radiologists do not simply label a kidney cyst “benign” or “suspicious” and leave it at that. Since the 1980s, they have used a grading system called the Bosniak classification to sort cystic kidney lesions into categories based on their appearance on contrast-enhanced CT. The system runs from category I (a thin-walled, water-density cyst with nothing interesting inside) through category IV (a cyst with large solid nodules or other overtly worrisome features). Each step up the ladder corresponds to a higher chance of malignancy.

A systematic review and meta-analysis pooling data from dozens of studies calculated the malignancy rates across all five Bosniak categories. For category I cysts, the pooled cancer rate was about 3%, essentially at the floor of imaging noise. Category II cysts came in around 6%, and category IIF (the “F” stands for follow-up) was similar at about 7%. The risk jumped sharply for category III lesions, with about 55% turning out to be malignant, and category IV lesions were malignant roughly 91% of the time.⁶

Those numbers tell a clear story. If your imaging report says Bosniak I or II, you are almost certainly dealing with a benign cyst. If it says Bosniak IV, surgery is typically recommended because the odds strongly favor cancer. Category III is the gray zone where about half of lesions are malignant and half are benign, which is why these lesions generate so much discussion between patients and their urologists. One single-center study found that 60% of surgically removed Bosniak III lesions were malignant, and all the cancers found were low-grade with no sign of progression.⁷

What Makes a Cyst Look Suspicious on Imaging

A perfectly round, thin-walled cyst filled with clear fluid is about as benign as a kidney finding gets. The features that push a cyst up the Bosniak ladder, and raise the cancer question, are structural irregularities visible on contrast-enhanced imaging. Key red flags include thickened cyst walls, internal septa (thin dividers inside the cyst), solid nodules growing from the wall, irregular contours, and areas that light up brightly after contrast dye is injected.

An MRI study of complex renal cysts quantified how strongly individual features predicted cancer. Among lesions with irregular walls, 63% were malignant. When solid nodules grew from the cyst wall, 75% were malignant. Thick walls (over 2 mm) were associated with a 71% malignancy rate. The single strongest predictor was the combination of irregular walls and intense enhancement after contrast injection.⁸ In other words, one worrisome feature by itself raises an eyebrow; two or more together raise the likelihood of cancer substantially.

This is also where diagnostic confusion can creep in. Renal abscesses caused by bacterial infection can look almost identical to a cystic kidney cancer on imaging, with thick walls, internal debris, and enhancement patterns that mimic a tumor. Inflammatory changes in the tissue surrounding the kidney tend to favor infection over cancer, but the overlap is real enough that some patients end up in surgery for what turns out to be an abscess.⁹ Hemorrhagic cysts (simple cysts that have bled internally) can also mimic malignancy on imaging, creating false alarms.¹⁰

Which Imaging Method Is Best

The Bosniak system was originally built around contrast-enhanced CT, and CT remains the reference standard for classifying cystic kidney lesions. MRI and contrast-enhanced ultrasound (CEUS) are alternatives, and each has trade-offs. MRI avoids radiation and is generally very good at characterizing cystic lesions. One prospective comparison found that MRI agreed with CT in classifying cystic lesions about 94% of the time and achieved both high sensitivity and high specificity for malignancy.¹¹

CEUS is newer to this particular role and its results have been mixed. In that same study, CEUS agreed with CT only about half the time and had a tendency to overcall benign lesions as suspicious, giving it poor specificity. A different prospective study, however, found CEUS performed excellently, with perfect sensitivity and very high specificity.¹² The inconsistency between studies reflects the fact that CEUS is highly operator-dependent, and the Bosniak criteria have not yet been fully adapted to it. For now, CT is still recommended as the primary tool, and both MRI and CEUS can play supporting roles, especially when repeated imaging is needed and minimizing radiation exposure matters.¹³

When a Cystic Lesion Turns Out to Be Cancer

Not all cystic kidney cancers behave the same way. Most cystic renal cell carcinomas are the clear cell subtype, the most common form of kidney cancer in general. But there is a distinct entity called multilocular cystic renal neoplasm of low malignant potential, which the World Health Organization reclassified from a cancer to a borderline tumor in 2016 because of its extremely favorable behavior. In one study, none of the patients with this tumor type developed recurrences or spread after surgery. Among predominantly cystic clear cell carcinomas, which are a step more aggressive, only one patient out of the entire cohort developed a distant spread.¹⁴ Compare that to standard (non-cystic) clear cell renal cell carcinoma, where the same study reported a five-year progression-free survival of only about 58%.

The practical takeaway is that even when a cystic kidney lesion does harbor cancer, the cancer tends to be lower-grade and less aggressive than a solid kidney tumor. This does not mean it can be ignored, but it does mean the prognosis is generally better.

Monitoring Category IIF Cysts

Category IIF cysts are the ones your radiologist flags for periodic follow-up imaging rather than immediate action. The “IIF” designation means the cyst has a few mildly complex features, enough that ignoring it entirely feels premature, but not enough to warrant surgery. The recommended approach is surveillance with repeat CT or MRI at regular intervals.

A study tracking 181 Bosniak IIF cysts over a median follow-up of about four years found that only about 2% progressed to a higher-risk category, and only one patient among those who had surgery turned out to have a malignancy. No malignant progression was observed after 36 months of stable imaging.¹⁵ That timeline matters: if a IIF cyst has looked the same on two or three follow-up scans over three years, the chance of it suddenly becoming cancerous is extremely small. Many urologists will stop active surveillance at that point.

Treatment Options When Surgery Is Needed

For cystic lesions that warrant removal, the two main approaches are partial nephrectomy (removing the cyst and a margin of kidney tissue) and thermal ablation (destroying the lesion with heat or cold via a needle inserted through the skin). Both are well-established. A registry-based analysis comparing the two found no significant difference in local recurrence, disease progression, or cancer-specific death. Thermal ablation did carry a lower perioperative burden, with shorter hospital stays and fewer complications.¹⁶ The choice between them depends on the size and location of the lesion, the patient’s overall health, and surgeon preference. For smaller cystic tumors, thermal ablation is increasingly favored because it preserves more kidney tissue and involves a quicker recovery.

Polycystic Kidney Disease and Cancer Risk

Polycystic kidney disease (PKD) is a genetic condition in which hundreds of cysts develop in both kidneys over time, eventually impairing kidney function. The individual cysts in PKD are overwhelmingly benign, but the disease itself is linked to a modestly elevated risk of certain cancers. A large population-based study found that people with PKD had roughly 2.5 times the risk of kidney cancer compared to matched controls without the disease. The same study also found elevated risks for liver and colon cancer.¹⁷

Despite the elevated relative risk, the absolute risk of any individual person with PKD developing kidney cancer remains low. The challenge with PKD is that the kidneys are already so distorted by cysts that detecting a new suspicious lesion on imaging is harder than in a normal kidney. Radiologists monitoring PKD patients pay particular attention to any cyst that looks different from the rest or changes rapidly.

Acquired Cystic Kidney Disease in Dialysis Patients

There is a separate condition, unrelated to genetics, called acquired cystic kidney disease (ACKD). It develops in people whose kidneys have failed and who are on long-term dialysis. Over years of dialysis, non-functioning kidneys tend to develop multiple cysts, and these carry a dramatically higher cancer risk than the cysts found in healthy kidneys. The risk of renal tumors in ACKD has been estimated at more than 100 times that of the general population, and about 80% of kidney cancers in end-stage renal disease occur in kidneys affected by ACKD.¹⁸¹⁹

The type of cancer that develops in ACKD, known as acquired cystic disease-associated renal cell carcinoma, is now recognized as its own distinct subtype. It tends to behave somewhat better than the more common forms of kidney cancer, but the frequency with which it develops in this population is the concern. Screening recommendations for dialysis patients remain a subject of debate, but many transplant programs image the native kidneys before and after transplantation to catch these tumors.

Kidney Cysts in Children

Renal cysts in children follow different rules than in adults. Simple cysts are far less common in pediatric patients, and when a child does have kidney cysts, the likelihood that they stem from a genetic condition is much higher. An international working group consensus statement noted that in children, a larger proportion of kidney cysts are caused by genetic diseases compared to adults, where simple and acquired cysts dominate.²⁰

The cancer considerations in children also differ. In a pediatric series evaluating complex cystic kidney lesions, about 10% turned out to be Wilms tumor, the most common childhood kidney cancer.²¹ The standard adult Bosniak system was not designed with children in mind, and pediatric radiologists rely on different criteria, including the clinical context and genetic testing, to decide how aggressively to investigate a cystic kidney lesion in a child.

The Anxiety Factor

Finding a cyst on a kidney scan creates worry that frequently exceeds the actual risk. A randomized study tested how the way risk information is communicated affects patient anxiety. When patients learned about a small renal finding using only verbal descriptions like “low risk,” they reported more worry and were more likely to want a surgical consultation than patients who received the same information with actual numbers and graphics. In the descriptive-only group, about 47% favored seeing a surgeon. In the group given numeric and visual risk data, that dropped to about 29%.²² Regardless of how the information was framed, patients consistently overestimated the actual risk of something going wrong.

This matters because incidental renal cysts, ones found on scans done for unrelated reasons, are incredibly common. The scan that found the cyst may have been ordered for back pain or an unrelated abdominal complaint. When the report mentions a kidney cyst, it is natural to jump to worst-case scenarios. The evidence consistently shows that for simple and minimally complex cysts, the actual cancer risk is low enough that watchful waiting is appropriate, and that understanding the specific numbers tends to ease the emotional burden.

AI Tools for Cyst Classification

One area of active research is training machine-learning models to classify cystic kidney lesions from CT scans, potentially reducing variability between radiologists and catching subtle features that a human eye might miss. A multicenter deep learning study reported near-perfect performance in predicting malignancy risk, with accuracy above 98% in its test dataset.²³ A separate study using radiomics, which extracts quantitative texture and shape data from CT images, found that machine-learning models could distinguish between Bosniak IIF and III cysts with accuracy above 90%.²⁴ Another group reported that a modified deep learning architecture outperformed a traditional algorithm in classifying Bosniak stages.²⁵

These are promising results, but all of these tools remain in the research phase. None are yet standard in clinical practice. The Bosniak IIF-to-III boundary is exactly where the stakes are highest, since crossing that line can determine whether a patient gets surveillance or surgery. If AI can reliably call that distinction, it could reduce both unnecessary operations and missed cancers. For now, though, a radiologist reading the scan and a urologist evaluating the clinical picture remain the decision-makers.

Experimental Biomarkers in Cyst Fluid

When a cyst is aspirated (drained with a needle), the fluid inside it can be analyzed for molecular markers. One protein, called CA9, was found at very high levels in the fluid of all 16 cystic malignant tumors tested in one study but was nearly absent in benign cysts. The difference was stark enough that the researchers proposed it as a diagnostic tool for telling cancerous cysts apart from harmless ones.²⁶ Another group identified a different protein, 14-3-3 beta/alpha, that was overexpressed in cyst fluid from cyst-associated renal cell carcinoma and had not previously been linked to kidney cancer.²⁷

Neither marker has moved into routine clinical use. Aspirating cyst fluid is itself an invasive step that most clinicians avoid unless the imaging is already concerning, so the question becomes whether fluid analysis adds enough value over imaging alone to justify the needle. In selected cases where imaging is ambiguous and the patient prefers to avoid surgery, cyst fluid analysis could eventually become a useful tiebreaker, but the validation studies needed to get there have not been completed.